Status
Conditions
Treatments
About
This is a randomized, controlled, double-blind, intervention trial of healthy male and female term infants to evaluate the efficacy of the 2 HMOs on beneficially modulating the gut microbiota, gut maturation, gut barrier integrity, immune response, and other developmental outcomes in healthy Chinese infants. The trial consists of 2 randomized formula-fed groups, and a non-randomized breastfed reference group.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
Primary purpose
Allocation
Interventional model
Masking
262 participants in 3 patient groups
Loading...
Central trial contact
Qiaoji Li; Joyce Li
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal